InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Zura Bio Ltd

ZURA Clue Score40
United States Fiscal year ends December CIK 0001855644
$4.00 +0.00% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.00 −59.35% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 3 Sep 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2022Operating income−27.2Net income−25.7EPS, diluted−141.97Fiscal year 2023Operating income−62.6Net income−60.4EPS, diluted−2.09Fiscal year 2024Operating income−55.2Net income−52.4EPS, diluted−0.60Fiscal year 2025Operating income−75.2Net income−68.7EPS, diluted−1.06
FY2022FY2023FY2024FY2025
Operating income −27.2 −62.6 −55.2 −75.2
Net income −25.7 −60.4 −52.4 −68.7
Growth
EPS, diluted −141.97 −2.09 −0.60 −1.06

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−1.2Fiscal year 2023Operating cash flow−15.1Fiscal year 2024Operating cash flow−28.1Capital expenditure−0.1Free cash flow−28.2Fiscal year 2025Operating cash flow−64.8Capital expenditure−0.1Free cash flow−64.9
FY2022FY2023FY2024FY2025
Operating cash flow −1.2 −15.1 −28.1 −64.8
Capital expenditure n/a n/a −0.1 −0.1
Free cash flow n/a n/a −28.2 −64.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2022Cash0.0Shareholders’ equity−32.1Fiscal year 2023Cash99.8Shareholders’ equity59.3Fiscal year 2024Cash176.5Shareholders’ equity146.8Fiscal year 2025Cash109.4Shareholders’ equity101.5
FY2022FY2023FY2024FY2025
Cash 0.0 99.8 176.5 109.4
Shareholders’ equity −32.1 59.3 146.8 101.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
n/a −101.7% −35.7% −67.6%
−488.4% −59.9% −29.2% −60.2%
Balance and payout
281.6% 21.1% 10.9% 10.9%